Summary
Ciclosporin is a lipophilic cyclic endecapeptide that was isolated from the soil fungus Tolypocladium infatum in the 1970s [1]. The initial formulation of ciclosporin (Sandimmun®) was approved in 1983 for the prevention of acute allograft rejection in organ transplants. The microemulsion formulation (Neoral®), with improved bioavailability, was approved in 1997 for the treatment of psoriasis and rheumatoid arthritis.
×
N.B. : This limited content is for the general public. If you are a health professional, click here to register for free and gain access to a dedicated deeper content.
If you already have an account, log in!
Therapeutics in Dermatology, Fondation René Touraine © 2001-2016
